Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medico-GDM trial of metformin to prevent gestational diabetes in high-risk pregnancy
NL-OMON41912Phase 3Active, not recruiting
- Sponsor
- Maasstad Ziekenhuis
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of metformin in gestational diabetes mellitus (GDM) (2 arms), sponsored by Maasstad Ziekenhuis. Primary endpoint: Incidence of gestational diabetes mellitus. Started Oct 2014; status: active, not recruiting.
02
Drugs
metformin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NL-OMON41912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41912.